Vitamin D Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal Feed, Pharmaceuticals, Food & Beverages, Personal Care, Others), By Region and Competition, 2020-2030F

Description

The Global Vitamin D Market was valued at USD 116.76 Million in 2024 and is projected to reach USD 166.18 Million by 2030, registering a CAGR of 5.22%. Often referred to as the "sunshine vitamin," Vitamin D has gained increasing recognition for its preventive health attributes and therapeutic relevance. Rising cases of Vitamin D deficiency, driven by reduced sun exposure, sedentary lifestyles, and inadequate dietary intake, are contributing to higher demand for supplementation. This need is particularly acute among older populations, who are more susceptible to bone-related conditions such as osteoporosis. The growing preference for preventive healthcare, ongoing clinical research into Vitamin D's broader health benefits, and innovations in delivery formats are further accelerating market growth. However, challenges such as evolving regulatory frameworks, supply chain inconsistencies, and regional disparities in natural synthesis of the vitamin continue to impact market dynamics. Despite these hurdles, the outlook for Vitamin D remains positive, fueled by increasing awareness and product diversification.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 116.76 Million
Market Size 2030	USD 166.18 Million
CAGR 2025-2030	5.22%
Fastest Growing Segment	Direct
Largest Market	North America

Key Market Drivers

Growth in Pharmaceutical Industry

The consistent growth of the global pharmaceutical sector, now valued at approximately USD 1.6 trillion as of 2023, has significantly influenced the Vitamin D market. As an essential nutrient for maintaining bone density, enhancing immune response, and reducing risks of chronic diseases, Vitamin D is being increasingly incorporated into pharmaceutical formulations. Rising global awareness of Vitamin D deficiency-especially among aging populations and individuals with limited sun exposure-has led to the launch of various supplements, tablets, and injectable products. For instance, in 2022, Arbro Pharmaceuticals introduced Vkap-D3, a plant-based supplement containing 60,000 IU of Vitamin D3 in a vegetarian capsule, tailored for effective deficiency treatment. Pharmaceutical advancements have also extended the vitamin's application across preventive therapies for conditions like osteoporosis, autoimmune disorders, and certain respiratory illnesses, thereby boosting market demand.

Key Market Challenges

Limited Consumer Awareness in Some Regions

A major challenge for the Vitamin D market is the lack of consumer awareness in several regions, particularly across parts of Asia, Africa, and Latin America. While developed markets are witnessing increased awareness regarding the consequences of Vitamin D deficiency, underserved regions often lack educational initiatives and healthcare infrastructure to support diagnosis and treatment. Limited awareness about deficiency symptoms-such as fatigue, muscle weakness, and bone discomfort-often results in misdiagnosis or neglect, thereby dampening demand for supplements. The absence of robust government-led health campaigns and nutritional literacy further contributes to the underdiagnosis and low product penetration in these regions.

Key Market Trends

Increasing Prevalence of Vitamin D Deficiency

The growing incidence of Vitamin D deficiency is emerging as a dominant trend in shaping the global market. Countries such as India, Pakistan, Tunisia, and Afghanistan report alarmingly low 25(OH)D levels in over 20% of their populations, with India alone accounting for approximately 490 million affected individuals. Contributing factors include decreased outdoor activity, urban living conditions, excessive sunblock use, and dietary preferences lacking sufficient natural sources of the vitamin. These patterns have resulted in a surge in demand for supplementation and fortified products. Healthcare professionals increasingly recommend Vitamin D intake to address a wide range of conditions-from bone health to immune function-prompting higher adoption of both clinical and consumer-grade formulations.

Key Market Players

Zhe jiang Garden Biopharmaceutical Co., Ltd.
Zhejiang Xinhecheng Co Ltd
Xiamen Jindawei Vitamin Co., Ltd
Fermenta Biotech Ltd
Taizhou Haisheng Pharmaceutical Co Ltd
Zhejiang Medicine Co., Ltd
ZHEJIANG WEISHI BIOTECHNOLOGY CO., LTD.
DSM-Firmenich
Xi'an Healthful Biotechnology Co., Ltd.
CARBOGEN AMCIS

Report Scope

In this report, the Global Vitamin D Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin D Market, By Sales Channel:

Direct
Indirect

Vitamin D Market, By End Use:

Animal Feed
Pharmaceuticals
Food & Beverages
Personal Care
Others

Vitamin D Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin D Market.

Available Customizations

Global Vitamin D Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin D Market

5. Global Vitamin D Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Animal Feed, Pharmaceuticals, Food & Beverages, Personal Care, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Vitamin D Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Vitamin D Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Sales Channel
    - 6.3.1.2.2. By End Use
- 6.3.2. Mexico Vitamin D Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Sales Channel
    - 6.3.2.2.2. By End Use
- 6.3.3. Canada Vitamin D Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Sales Channel
    - 6.3.3.2.2. By End Use

7. Europe Vitamin D Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Vitamin D Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Sales Channel
    - 7.3.1.2.2. By End Use
- 7.3.2. Germany Vitamin D Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Sales Channel
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Vitamin D Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Sales Channel
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Vitamin D Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Sales Channel
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Vitamin D Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Sales Channel
    - 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin D Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Vitamin D Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Sales Channel
    - 8.3.1.2.2. By End Use
- 8.3.2. India Vitamin D Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Sales Channel
    - 8.3.2.2.2. By End Use
- 8.3.3. South Korea Vitamin D Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Sales Channel
    - 8.3.3.2.2. By End Use
- 8.3.4. Japan Vitamin D Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Sales Channel
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Vitamin D Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Sales Channel
    - 8.3.5.2.2. By End Use

9. South America Vitamin D Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Vitamin D Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Sales Channel
    - 9.3.1.2.2. By End Use
- 9.3.2. Argentina Vitamin D Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Sales Channel
    - 9.3.2.2.2. By End Use
- 9.3.3. Colombia Vitamin D Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Sales Channel
    - 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin D Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Vitamin D Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Sales Channel
    - 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Vitamin D Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Sales Channel
    - 10.3.2.2.2. By End Use
- 10.3.3. UAE Vitamin D Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Sales Channel
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Vitamin D Market: SWOT Analysis

14. Porters Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zhe jiang Garden Biopharmaceutical Co.,Ltd.
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Zhejiang Xinhecheng Co Ltd
15.3. Xiamen Jindawei Vitamin Co., Ltd
15.4. Fermenta Biotech Ltd
15.5. Taizhou Haisheng Pharmaceutical Co Ltd
15.6. Zhejiang Medicine Co., Ltd
15.7. ZHEJIANG WEISHI BIOTECHNOLOGY CO.,LTD.
15.8. DSM-Firmenich
15.9. Xi'an Healthful Biotechnology Co., Ltd.
15.10. CARBOGEN AMCIS